SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-296742
Filing Date
2023-12-15
Accepted
2023-12-15 16:51:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d67519dsc13ga.htm SC 13G/A 43564
  Complete submission text file 0001193125-23-296742.txt   45103
Mailing Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900
Business Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900 45 8824 8824
Novo Holdings A/S (Filed by) CIK: 0001388325 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Subject) CIK: 0001907108 (see all company filings)

IRS No.: 854012572 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-94231 | Film No.: 231491072
SIC: 2836 Biological Products, (No Diagnostic Substances)